Abourehab MAS - Search Results

1

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens.

Al-Warhi T, Elimam DM, Elsayed ZM, Abdel-Aziz MM, Maklad RM, Al-Karmalawy AA, Afarinkia K, Abourehab MAS, Abdel-Aziz HA, Eldehna WM. Al-Warhi T, et al. Among authors: abourehab mas. RSC Adv. 2022 Nov 2;12(48):31466-31477. doi: 10.1039/d2ra04385h. eCollection 2022 Oct 27. RSC Adv. 2022. PMID: 36382148 Free PMC article.

2

Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights.

Eldehna WM, Maklad RM, Almahli H, Al-Warhi T, Elkaeed EB, Abourehab MAS, Abdel-Aziz HA, El Kerdawy AM. Eldehna WM, et al. Among authors: abourehab mas. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1227-1240. doi: 10.1080/14756366.2022.2062337. J Enzyme Inhib Med Chem. 2022. PMID: 35470754 Free PMC article.

3

Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review.

Abdelgawad SM, Hassab MAE, Abourehab MAS, Elkaeed EB, Eldehna WM. Abdelgawad SM, et al. Among authors: abourehab mas. Front Pharmacol. 2022 Apr 13;13:879118. doi: 10.3389/fphar.2022.879118. eCollection 2022. Front Pharmacol. 2022. PMID: 35496299 Free PMC article.

4

A patent review of anticancer CDK2 inhibitors (2017-present).

Said MA, Abdelrahman MA, Abourehab MAS, Fares M, Eldehna WM. Said MA, et al. Among authors: abourehab mas. Expert Opin Ther Pat. 2022 Aug;32(8):885-898. doi: 10.1080/13543776.2022.2078193. Epub 2022 May 26. Expert Opin Ther Pat. 2022. PMID: 35583393 Review.

5

Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors.

Belal A, Abdel Gawad NM, Mehany ABM, Abourehab MAS, Elkady H, Al-Karmalawy AA, Ismael AS. Belal A, et al. Among authors: abourehab mas. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1884-1902. doi: 10.1080/14756366.2022.2096019. J Enzyme Inhib Med Chem. 2022. PMID: 35801486 Free PMC article.

6

GC-MS metabolites profiling of anethole-rich oils by different extraction techniques: antioxidant, cytotoxicity and in-silico enzymes inhibitory insights.

El-Kersh DM, Mostafa NM, Fayez S, Al-Warhi T, Abourehab MAS, Eldehna WM, Salem MA. El-Kersh DM, et al. Among authors: abourehab mas. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1974-1986. doi: 10.1080/14756366.2022.2097445. J Enzyme Inhib Med Chem. 2022. PMID: 35850583 Free PMC article.

7

The old world salsola as a source of valuable secondary metabolites endowed with diverse pharmacological activities: a review.

ElNaggar MH, Eldehna WM, Abourehab MAS, Abdel Bar FM. ElNaggar MH, et al. Among authors: abourehab mas. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2036-2062. doi: 10.1080/14756366.2022.2102005. J Enzyme Inhib Med Chem. 2022. PMID: 35875938 Free PMC article. Review.

8

In Silico Docking, Resistance Modulation and Biofilm Gene Expression in Multidrug-Resistant Acinetobacter baumannii via Cinnamic and Gallic Acids.

Abdelaziz NA, Elkhatib WF, Sherif MM, Abourehab MAS, Al-Rashood ST, Eldehna WM, Mostafa NM, Elleboudy NS. Abdelaziz NA, et al. Among authors: abourehab mas. Antibiotics (Basel). 2022 Jun 28;11(7):870. doi: 10.3390/antibiotics11070870. Antibiotics (Basel). 2022. PMID: 35884124 Free PMC article.

9

Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity.

Eldehna WM, El Hassab MA, Elsayed ZM, Al-Warhi T, Elkady H, Abo-Ashour MF, Abourehab MAS, Eissa IH, Abdel-Aziz HA. Eldehna WM, et al. Among authors: abourehab mas. Sci Rep. 2022 Jul 27;12(1):12821. doi: 10.1038/s41598-022-15050-8. Sci Rep. 2022. PMID: 35896557 Free PMC article.

10

Removal of hexavalent chromium ions using micellar modified adsorbent: isothermal and kinetic investigations.

Sarfraz S, Ameer S, Javed M, Iqbal S, Aljazzar SO, Zahra M, Amin S, Shah KH, Abourehab MAS, Elkaeed EB, Awwad NS, Ibrahium HA. Sarfraz S, et al. Among authors: abourehab mas. RSC Adv. 2022 Aug 24;12(37):23898-23911. doi: 10.1039/d2ra03906k. eCollection 2022 Aug 22. RSC Adv. 2022. PMID: 36093227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page